NEWS RELEASE TRANSMITTED BY Marketwire

FOR: NUTTER MCCLENNEN & FISH

Nutter's Life Sciences Group Hosts Executive Forum on May 2nd

APR 25, 2012 - 13:31 ET

The Business of Invention: Patenting for Biotechs

BOSTON, MA--(Marketwire - April 25, 2012) - The Life Sciences Group of the law firm of Nutter McClennen & Fish LLP will present The Business of Invention: Patenting for Biotechs on Wednesday, May 2^nd from 7:30 - 9:30 a.m., a forum for biotech executives and general counsel, BD, CSOs and biomedical inventors involved in the creation and commercialization of IP. The forum will be held at Nutter's office at 155 Seaport Boulevard in Boston.

For a full description of this event, and to register, please go to: http://businessofinvention.eventbrite.com/ or call 617-439-2985.

Konstantin Linnik, Ph.D., a partner in the firm's IP and Life Sciences practice groups and a former senior counsel at Pfizer, will present on the following topics:

• What to patent and what to keep as a trade secret
• How to properly maintain lab notebooks
• How to address competitors' IP and freedom to operate
• Implications of the new US patent reform

About Nutter McClennen & Fish LLP
Nutter McClennen & Fish LLP has a long track record working with life sciences companies throughout the product lifecycle to achieve their legal and business objectives. The firm represents an international roster of innovative clients involved in a range of sophisticated technologies in the biotechnology, medical device, and pharmaceutical industries, as well as renowned medical institutions and research universities, emerging growth companies and angel and venture capital firms. Nutter's expertise spans IP strategy, prosecution and litigation; strategic collaborations and licensing; clinical trials and regulatory compliance; as well as M&A, capital raising and finance, government investigations and defense, and product liability.

FOR FURTHER INFORMATION PLEASE CONTACT:

Contact:
Lisa Jentzen
617-439-2894